MARIE BAZILE: Open Payments
NPI 1174248041 · LANCASTER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$386 in 8 payments from 5 companies in 2025. Trend: 2023 $95 · 2024 $70 · 2025 $386
Food & beverage: $195Education: $191
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $196 |
| E.R. Squibb & Sons, L.L.C. | 1 | $99 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| Neurocrine BioSciences, Inc. | 1 | $26 |
| ACADIA Pharmaceuticals Inc | 1 | $22 |
Products named: COBENFY, REXULTI, INGREZZA, NUPLAZID, AUSTEDO XR.
Industry payments across MA — which companies pay providers there.
